Inflammatory infiltrates of experimental mammary cancers.
暂无分享,去创建一个
W. Wei | G. Heppner | W Z Wei | S Ratner | A M Fulton | G H Heppner | A. Fulton | S. Ratner | W. Wei | W. Wei
[1] H. Macdonald,et al. Quantitation and clonal isolation of cytolytic T lymphocyte precursors selectively infiltrating murine sarcoma virus-induced tumors , 1981, The Journal of experimental medicine.
[2] D. Durant,et al. Migration of human helper/inducer T cells in response to supernatants from Con A-stimulated suppressor/cytotoxic T cells. , 1983, Journal of immunology.
[3] J. Mulé,et al. Selective localization of radiolabeled immune lymphocytes into syngeneic tumors. , 1979, Journal of immunology.
[4] C. Boone,et al. Changes in the homing properties of labeled lymphoid cells caused by solid tumor growth. , 1974, Cellular immunology.
[5] R. Williams,et al. T-lymphocyte subpopulations in peripheral blood and tissues of cancer patients. , 1980, Cancer research.
[6] G. Wolterink,et al. Effects of endotoxin‐treatment on inflammatory cell infiltrates in murine meth A sarcoma , 1985, The Journal of pathology.
[7] R. Williams,et al. Human-B and T-lymphocyte locomotion in response to casein, C5a, and f-met-leu-phe. , 1980, Cellular immunology.
[8] K. A. Wall,et al. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule. , 1983, Journal of immunology.
[9] I. McKenzie,et al. An analysis of T lymphocyte subsets in tumour-transplanted mice on the basis of Lyt antigenic markers and functions. , 1982, Immunology.
[10] W. Wei,et al. Characterization of lymphocytic infiltrates in normal, preneoplastic, and neoplastic mouse mammary tissues. , 1986, Cancer research.
[11] H. Whitwell,et al. Expression of major histocompatibility antigens and leucocyte infiltration in benign and malignant human breast disease. , 1984, British Journal of Cancer.
[12] I. Weissman,et al. Differences in the migration of B and T lymphocytes: organ-selective localization in vivo and the role of lymphocyte-endothelial cell recognition. , 1982, Journal of immunology.
[13] G. Heppner,et al. Mutagenic activity of tumor-associated macrophages in Salmonella typhimurium strains TA98 and TA 100. , 1984, Cancer research.
[14] F. Orr,et al. Chemotaxis of large granular lymphocytes. , 1986, Journal of immunology.
[15] J. Vaage,et al. Morphological observations during developing concomitant immunity against a C3H/He mammary tumor. , 1985, Cancer research.
[16] G. Heppner,et al. In situ lymphoid cells of mouse mammary tumors. II. The characterization of lymphoid cells separated from mouse mammary tumors. , 1978, Journal of immunology.
[17] W. Nelson-Rees,et al. Bovine leukemia: establishment and morphologic characterization of continuous cell suspension culture, BL-1. , 1968, Journal of the National Cancer Institute.
[18] R. Snyderman,et al. Inhibitors of monocyte responses to chemotaxins are associated with human neoplasms. , 1982, Advances in experimental medicine and biology.
[19] H. Whitwell,et al. Distribution of histocompatibility and leucocyte differentiation antigens in normal human colon and in benign and malignant colonic neoplasms. , 1984, British Journal of Cancer.
[20] Craig W. Reynolds,et al. Natural killer activity in the rat. IV. Distribution of large granular lymphocytes (LGL) following intravenous and intraperitoneal transfer. , 1984, Cellular immunology.
[21] H. Muller,et al. Lymphocyte migration during the development of regional lymph node anergy in experimental tumor growth. , 1983, Cellular immunology.
[22] G. Heppner,et al. Heterogeneity of expression and induction of mouse mammary tumor virus antigens in mouse mammary tumors. , 1982, Cancer research.
[23] P. Beverley,et al. Characterisation of breast cancer infiltrates using monoclonal antibodies to human leucocyte antigens. , 1984, British Journal of Cancer.
[24] L. Milas,et al. Stimulated granulocytopoiesis in mice bearing fibrosarcoma. , 1972, European journal of cancer.
[25] M. Kasai,et al. A glycolipid on the surface of mouse natural killer cells , 1980, European journal of immunology.
[26] J. Hurlimann,et al. Mononuclear cells infiltrating human mammary carcinomas: Immunohistochemical analysis with monoclonal antibodies , 1985, International journal of cancer.
[27] E. Unanue,et al. Chemotaxis of rat lymphocytes. , 1977, Journal of immunology.
[28] R. Snyderman,et al. Abnormalities of Monocyte Chemotaxis in Patients With Melanoma: Effects of Immunotherapy and Tumor Removal , 1977 .
[29] E. Cronkite,et al. Tumor-induced granulopoiesis unrelated to colony-stimulating factor. , 1983, Blood.
[30] P. Steerenberg,et al. Selective localization of tumor-immune spleen cells at the tumor challenge site after adoptive transfer of line 10 tumor immunity in strain 2 guinea pigs. , 1985, Journal of immunology.
[31] P. Wilkinson. Chemotaxis and inflammation , 1974 .
[32] A. Miller,et al. Lymphoreticular cells isolated by centrifugal elutriation from a mammary adenocaricinoma. i. characterization of an in situ lymphocyte suppressor population by surface markers and functional reactivity , 1984, International journal of cancer.
[33] A. Mantovani,et al. Chemotactic activity for mononuclear phagocytes of culture supernatants from murine and human tumor cells: Evidence for a role in the regulation of the macrophage content of neoplastic tissues , 1983, International journal of cancer.
[34] S. Haskill,et al. Mononuclear-cell infiltration in ovarian cancer. II. Immune function of tumour and ascites-derived inflammatory cells. , 1982, British Journal of Cancer.
[35] J. Varani,et al. Expression of a laminin-like substance on the surface of murine natural killer (NK) lymphocytes and its role in NK recognition of tumor target cells. , 1985, Journal of immunology.
[36] B. Zwilling,et al. Prostaglandin regulation of macrophage function: effect of endogenous and exogenous prostaglandins. , 1982, Cellular immunology.
[37] I. Weissman,et al. A cell-surface molecule involved in organ-specific homing of lymphocytes , 1983, Nature.
[38] C. Yu,et al. Lymphocyte chemotactic activity of human interleukin 1. , 1984, Journal of immunology.
[39] P. Allavena,et al. In vitro migration of human large granular lymphocytes. , 1985, Journal of immunology.
[40] J. Berman,et al. Induction of human T lymphocyte motility by interleukin 2. , 1985, Journal of immunology.
[41] I. Weissman,et al. Differences in in vivo distribution and homing of T cell subsets to mucosal vs nonmucosal lymphoid organs. , 1983, Journal of immunology.
[42] J. Mulé,et al. Cell surface phenotypes of radiolabeled immune long-lived lymphocytes that selectively localize in syngeneic tumours. , 1982, The American journal of pathology.
[43] S. Weitzman,et al. Phagocytes as carcinogens: malignant transformation produced by human neutrophils. , 1985, Science.
[44] D. Parrott,et al. Locomotion of human lymphoid cells. I. Effect of culture and con A on T and non-T lymphocytes. , 1977, Cellular immunology.
[45] C. Rosse,et al. Induction of granulocytic hyperplasia, thymic atrophy, and hypercalcemia by a selected subpopulation of a murine mammary adenocarcinoma. , 1985, Cancer research.
[46] K. von der Mark,et al. Laminin and its receptor. , 1985, Biochimica et biophysica acta.
[47] S. Weitzman,et al. Effects of oxygen radical scavengers and antioxidants on phagocyte-induced mutagenesis. , 1982, Journal of immunology.
[48] L. Liotta,et al. Identification and partial characterization of a low-molecular-weight inhibitor of leukotaxis from fibrosarcoma cells. , 1984, Cancer research.
[49] E. M. Lawler,et al. Macrophage content and immunogenicity of C57BL/6J and BALB/cByJ methylcholanthrene‐induced sarcomas , 1980, International journal of cancer.
[50] E. Lord,et al. Assessment of in situ host immunity to syngeneic tumors utilizing the multicellular spheroid model. , 1984, Cellular immunology.
[51] L. Herzenberg,et al. T cell subsets defined by expression of Lyt-1,2,3 and Thy-1 antigens. Two-parameter immunofluorescence and cytotoxicity analysis with monoclonal antibodies modifies current views , 1980, The Journal of experimental medicine.
[52] S. Eccles,et al. Macrophage content of tumours in relation to metastatic spread and host immune reaction , 1974, Nature.
[53] R. Herberman,et al. The Reticuloendothelial System , 2012, Springer US.
[54] H. Svaar,et al. Content and distribution of macrophages and lymphocytes in solid malignant human tumours , 1979, International journal of cancer.
[55] D. Dexter,et al. Heterogeneity of tumor cells from a single mouse mammary tumor. , 1978, Cancer research.
[56] S. Carter,et al. Haptotaxis and the Mechanism of Cell Motility , 1967, Nature.
[57] F. Miller,et al. Activity of lymphoid cells separated from mammary tumors in blastogenesis and Winn assays. , 1980, Journal of the National Cancer Institute.
[58] R. Daynes,et al. Molecular mechanisms of lymphocyte extravasation. I. Studies of two selective inhibitors of lymphocyte recirculation. , 1984, Journal of immunology.
[59] R. Daynes,et al. Inhibition of lymphocyte and neutrophil chemotaxis by pertussis toxin. , 1985, Journal of immunology.
[60] D. Haskard,et al. Interleukin 1 increases the binding of human B and T lymphocytes to endothelial cell monolayers. , 1986, Journal of immunology.
[61] M. Moore,et al. Human tumor-infiltrating lymphocytes: a marker of host response. , 1985, Seminars in hematology.
[62] R. Evans. Macrophage accumulation in primary and transplanted tumors growing in C5‐deficient B10.D2/oSn mice , 1980, International journal of cancer.
[63] W. Becker,et al. Identification of inflammatory cell phenotypes in human oral carcinomas by means of monoclonal antibodies. , 1983, Archives of oral biology.
[64] H. Broxmeyer,et al. Role for monocyte-macrophage-derived colony-stimulating factor and prostaglandin E in the positive and negative feedback control of myeloid stem cell proliferation. , 1978, Blood.
[65] L. Kaizer,et al. POST‐MITOTIC AGE OF MONONUCLEAR CELLS MIGRATING INTO TA‐3(St) SOLID TUMORS , 1977, Cell and tissue kinetics.
[66] F. Miller,et al. In situ lymphoid cells of mouse mammary tumors. III. In vitro stimulation of tumor cell survival by lymphoid cells separated from mammary tumors. , 1978, Journal of immunology.
[67] I. Fidler,et al. Macrophage content of metastatic and nonmetastatic rodent neoplasms. , 1981, Journal of immunology.
[68] T. Yoshimura,et al. Chemotactic macrophage subpopulations defined by macrophage chemotactic factors from delayed hypersensitivity reaction sites. , 1983, Journal of Immunology.
[69] C. Rosse,et al. Depletion of lymphocyte subpopulations in primary and secondary lymphoid organs of mice by a transplanted granulocytosis-inducing mammary carcinoma. , 1982, Cancer research.
[70] W. Troll,et al. The role of oxygen radicals as a possible mechanism of tumor promotion. , 1985, Annual review of pharmacology and toxicology.
[71] J. Woodruff,et al. Lymphocyte recognition of lymph node high endothelium. IV. Cell surface structures mediating entry into lymph nodes. , 1982, Journal of immunology.
[72] J. McCarthy,et al. Laminin and fibronectin promote the haptotactic migration of B16 mouse melanoma cells in vitro , 1984, The Journal of cell biology.
[73] G. Heppner,et al. T cell locomotion in the tumor microenvironment. I. A collagen-matrix assay. , 1985, Journal of Immunology.
[74] A. Theodore,et al. Chemoattractant lymphokines specific for the helper/inducer T-lymphocyte subset. , 1985, Cellular immunology.
[75] D. V. Van Epps,et al. Human T-lymphocyte chemotactic activity: nature and production in response to antigen. , 1986, Cellular immunology.
[76] E. Leonard,et al. Abnormal monocyte chemotactic response in cancer patients. , 1974, Journal of the National Cancer Institute.
[77] S. Weitzman,et al. Mutation caused by human phagocytes. , 1981, Science.
[78] I. Weissman,et al. Cell surface molecule associated with lymphocyte homing is a ubiquitinated branched-chain glycoprotein. , 1986, Science.
[79] A. Fulton. Effects of indomethacin on the growth of cultured mammary tumors , 1984, International journal of cancer.
[80] M. Wicha,et al. Macrophages express cell surface laminin. , 1983, Experimental cell research.
[81] P. Bland,et al. Immunohistologic analysis of the T-cell and macrophage infiltrate in 1,2-dimethylhydrazine-induced colon tumors in the rat. , 1985, Journal of the National Cancer Institute.
[82] R. Simmons,et al. Maturation of cytotoxic T cells within sponge matrix allografts. , 1983, Journal of immunology.
[83] D. Medina. Mammary tumorigenesis in chemical carcinogen-treated mice. VI. Tumor-producing capabilities of mammary dysplasias in BALB/cCrgl mice. , 1976, Journal of the National Cancer Institute.
[84] G. Heppner,et al. Tumor-associated macrophages of mouse mammary tumors. I. Differential cytotoxicity of macrophages from metastatic and nonmetastatic tumors. , 1983, Journal of immunology.
[85] S. Tlouzeau,et al. Enhancement by serotonin of intra-tumour penetration of spleen cells. , 1984, British Journal of Cancer.
[86] C. Hardy,et al. High proliferation of granulocyte-macrophage progenitors in tumor-bearing mice. , 1983, Cancer research.
[87] P. Lala,et al. Changes in the host natural killer cell population in mice during tumor development. 1. Kinetics and in vivo significance. , 1985, Cellular immunology.
[88] H. Dvorak,et al. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. , 1983, Science.
[89] L. Weiss. Principles of metastasis , 1985 .